A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers

Conditions: Ovarian Cancer; Lung Cancer Interventions: Drug: [68Ga]Ga-EVS459; Drug: [177Lu]Lu-EVS459 Sponsors: Novartis Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials